64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA)
Clinical trial NCT05249127 · COMPLETED
Trial details
- NCT number
- NCT05249127
- Sponsor
- Clarity Pharmaceuticals Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-11
- Primary completion
- 2023-08-08
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.